Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB12319ApprovedWithdrawnSmall molecule
Benzbromarone is a uricosuric agent which is taken daily for the prevention of gout flares. Benzbromarone has been used in trials studying the basic science and treatment of Heart Failure, Hyperuricemia, Chronic Kidney Disease, Abnormal Renal Function, and Gout and Asymptomatic Hyperuricemia.
- Mechanism
- Curator reviewed
Pharmacologically active on Solute carrier family 22 member 12
- Formula / weight
- C17H12Br2O3 · 424.083 g/mol (avg)
- Code names
- L-2214 · MJ 10061
Resolves to
Clinical / RWD
Structure
InChIKey
WHQCHUCQKNIQEC-UHFFFAOYSA-NSMILESCCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=CC=CC=C2O1Transporters
What you can answer from here — as of June 15, 2026
5Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
3TransportersSubstrate / inhibitor direction, not just membership
Listed above
Which drugs share a target with Benzbromarone, and which of those have an active Phase 3 trial?